$CPTN
Cepton, Inc.

2023 Q4 Form 10-Q Financial Statement

#000149823323000087 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $4.951M $3.833M $1.804M
YoY Change 213.95% 112.47% -4.6%
Cost Of Revenue $2.255M $3.339M $1.875M
YoY Change 120.21% 78.08% 88.82%
Gross Profit $2.696M $494.0K -$71.00K
YoY Change 387.52% -795.77% -107.91%
Gross Profit Margin 54.45% 12.89% -3.94%
Selling, General & Admin $4.922M $6.136M $6.722M
YoY Change -26.26% -8.72% 559.02%
% of Gross Profit 182.57% 1242.11%
Research & Development $6.570M $6.706M $8.227M
YoY Change -24.0% -18.49% 29.95%
% of Gross Profit 243.69% 1357.49%
Depreciation & Amortization $126.0K $200.0K $77.00K
YoY Change 5.0% 159.74%
% of Gross Profit 4.67% 40.49%
Operating Expenses $11.49M $12.84M $14.95M
YoY Change -24.99% -14.09% 1365.59%
Operating Profit -$8.796M -$12.35M -$15.02M
YoY Change -40.43% -17.79% 1377.01%
Interest Expense $777.0K $790.0K -$318.0K
YoY Change -125.21% -348.43%
% of Operating Profit
Other Income/Expense, Net $112.0K $2.000K -$493.0K
YoY Change -96.85% -100.41% -90.84%
Pretax Income -$8.307M -$11.29M -$17.41M
YoY Change -45.55% -35.11% 172.39%
Income Tax $13.00K $0.00 $5.000K
% Of Pretax Income
Net Earnings -$8.320M -$11.29M -$17.41M
YoY Change -45.45% -35.13% 172.28%
Net Earnings / Revenue -168.05% -294.65% -965.13%
Basic Earnings Per Share -$0.71 -$0.11
Diluted Earnings Per Share -$0.52 -$0.71 -$0.11
COMMON SHARES
Basic Shares Outstanding 15.85M shares 158.2M shares 155.6M shares
Diluted Shares Outstanding 15.83M shares 155.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.38M $61.20M $21.62M
YoY Change 58.11% 183.1% 8907.5%
Cash & Equivalents $50.41M $43.90M $3.312M
Short-Term Investments $5.969M $17.30M $18.31M
Other Short-Term Assets $1.253M $2.400M $314.0K
YoY Change 226.3% 664.33% 528.0%
Inventory $2.396M $3.911M $2.516M
Prepaid Expenses
Receivables $3.625M $2.100M $1.386M
Other Receivables $0.00 $0.00 $865.0K
Total Short-Term Assets $63.65M $69.53M $30.86M
YoY Change 37.73% 125.32% 10753.45%
LONG-TERM ASSETS
Property, Plant & Equipment $1.450M $1.999M $840.0K
YoY Change 47.66% 137.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.35M $10.49M $1.137M
YoY Change 1945.05% 822.25%
Total Long-Term Assets $12.80M $13.77M $1.977M
YoY Change 212.04% 596.41% -98.85%
TOTAL ASSETS
Total Short-Term Assets $63.65M $69.53M $30.86M
Total Long-Term Assets $12.80M $13.77M $1.977M
Total Assets $76.45M $83.30M $32.84M
YoY Change 51.94% 153.69% -81.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.128M $1.400M $1.740M
YoY Change -43.0% -19.54% 200.0%
Accrued Expenses $5.551M $3.409M $3.399M
YoY Change 145.08% 0.29%
Deferred Revenue $367.0K $48.00K
YoY Change -30.1%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $7.069M $6.589M $5.792M
YoY Change -84.97% 13.76% 906.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $9.370M
YoY Change -100.0%
Other Long-Term Liabilities $8.856M $9.500M $5.239M
YoY Change 3051.6% 81.33% -62.55%
Total Long-Term Liabilities $8.856M $9.500M $14.61M
YoY Change 3051.6% -34.97% 4.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.069M $6.589M $5.792M
Total Long-Term Liabilities $8.856M $9.500M $14.61M
Total Liabilities $15.93M $16.04M $20.40M
YoY Change -67.29% -21.38% 40.06%
SHAREHOLDERS EQUITY
Retained Earnings -$134.6M -$126.3M -$70.81M
YoY Change 56.33% 78.37% 396.36%
Common Stock $0.00 $0.00 $2.000K
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.52M -$31.63M $12.43M
YoY Change
Total Liabilities & Shareholders Equity $76.45M $83.30M $32.84M
YoY Change 51.94% 153.69% -81.0%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$8.320M -$11.29M -$17.41M
YoY Change -45.45% -35.13% 172.28%
Depreciation, Depletion And Amortization $126.0K $200.0K $77.00K
YoY Change 5.0% 159.74%
Cash From Operating Activities -$4.993M -$9.290M -$11.23M
YoY Change -65.55% -17.28% 2239.79%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $100.0K -$17.00K
YoY Change -98.86% -688.24%
Acquisitions
YoY Change
Other Investing Activities $11.54M $20.00M $8.252M
YoY Change -21.23% 142.37%
Cash From Investing Activities $11.54M $19.89M $8.235M
YoY Change -20.28% 141.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.00K 10.00K 1.776M
YoY Change -99.96% -99.44%
NET CHANGE
Cash From Operating Activities -4.993M -9.290M -11.23M
Cash From Investing Activities 11.54M 19.89M 8.235M
Cash From Financing Activities 12.00K 10.00K 1.776M
Net Change In Cash 6.557M 10.61M -1.220M
YoY Change -77.64% -969.67% 154.17%
FREE CASH FLOW
Cash From Operating Activities -$4.993M -$9.290M -$11.23M
Capital Expenditures $2.000K $100.0K -$17.00K
Free Cash Flow -$4.995M -$9.390M -$11.21M
YoY Change -65.95% -16.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2549000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-757000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-22685000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6589000 usd
CY2023Q3 gcac Warrant Liability
WarrantLiability
141000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
93000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9217000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
16040000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5000000 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
us-gaap Revenues
Revenues
8105000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3339000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1875000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7251000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
494000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-71000 usd
us-gaap Gross Profit
GrossProfit
854000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6706000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8227000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23309000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6136000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6722000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19052000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
12842000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14949000 usd
us-gaap Operating Expenses
OperatingExpenses
42361000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12348000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15020000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-41507000 usd
CY2023Q3 gcac Gain Loss On Earnout Liabiity
GainLossOnEarnoutLiabiity
91000 usd
gcac Gain Loss On Earnout Liabiity
GainLossOnEarnoutLiabiity
827000 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
169000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-135000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
299000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1123000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
799000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-318000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2015000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11294000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17406000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40223000 usd
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 usd
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-5000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-3000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11294000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17411000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40226000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15568941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15750586 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15834152 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15568941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15750586 shares
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11294000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17411000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40226000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
13000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11289000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17400000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40199000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
16.89
CY2022Q1 gcac Warrant Liabilities Fair Value Disclosure
WarrantLiabilitiesFairValueDisclosure
1300000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1129000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
610000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
631000 usd
us-gaap Lease Cost
LeaseCost
2881000 usd
us-gaap Lease Cost
LeaseCost
1760000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15750586 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14274416 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
930427 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15568941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15750586 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15204843 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500219 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001498233
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2022Q4 gcac Temporary Equity Optional Redemption Period To Repurchase
TemporaryEquityOptionalRedemptionPeriodToRepurchase
P2Y
CY2022Q4 gcac Temporary Equity Optional Redemption Net Income Requirement Period
TemporaryEquityOptionalRedemptionNetIncomeRequirementPeriod
P5Y
CY2022Q4 gcac Temporary Equity Optional Redemption Related Party Redemption Period
TemporaryEquityOptionalRedemptionRelatedPartyRedemptionPeriod
P7Y
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31953000 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
3703000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1979000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2265000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
42587000 usd
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
100000 shares
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
100000 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15674781 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88058000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-366000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86059000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1633000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50316000 usd
us-gaap Revenues
Revenues
5849000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6208000 usd
us-gaap Gross Profit
GrossProfit
-359000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24368000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21954000 usd
us-gaap Operating Expenses
OperatingExpenses
46322000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-46681000 usd
CY2022Q3 gcac Gain Loss On Earnout Liabiity
GainLossOnEarnoutLiabiity
-1440000 usd
gcac Gain Loss On Earnout Liabiity
GainLossOnEarnoutLiabiity
70868000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-487000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1597000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24652000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-21000 usd
us-gaap Net Income Loss
NetIncomeLoss
24631000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15834152 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14274416 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15204843 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
24631000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-49000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24582000 usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1633000 usd
CY2023Q1 gcac Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2023Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
98891000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2280000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
17000 usd
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
20000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-14742000 usd
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
100000 shares
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
98891000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-10784000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2362000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
63000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-11000 usd
CY2023Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-4000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-14190000 usd
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
100000 shares
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
98891000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2332000 usd
CY2023Q3 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
5000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-11294000 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
100000 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
98891000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-31633000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2167149 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
99470000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-87531000 usd
CY2022Q1 gcac Temporary Equity Shares Retroactive Application Of Exchange Ratio
TemporaryEquitySharesRetroactiveApplicationOfExchangeRatio
3140708 shares
CY2022Q1 gcac Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
5307857 shares
CY2022Q1 gcac Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
99470000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
99471000 usd
CY2022Q1 gcac Stock Issued During Period Value Reverse Recapitalization Net Of Transaction Costs
StockIssuedDuringPeriodValueReverseRecapitalizationNetOfTransactionCosts
-33051000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
273000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1357000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-11000 usd
CY2022Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-4000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
41198000 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22249000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
211000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
38000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2229000 usd
CY2022Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
226000 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-37000 usd
CY2022Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-8000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
843000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
25349000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
261000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1831000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2368000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13000 usd
CY2022Q3 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-2000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-17411000 usd
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
12434000 usd
us-gaap Net Income Loss
NetIncomeLoss
-40226000 usd
us-gaap Net Income Loss
NetIncomeLoss
24631000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
370000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
224000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6989000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5954000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1177000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
993000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
682000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-838000 usd
gcac Increase Decrease In Earnout Liability
IncreaseDecreaseInEarnoutLiability
-827000 usd
gcac Increase Decrease In Earnout Liability
IncreaseDecreaseInEarnoutLiability
-70868000 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-299000 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-2549000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-757000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1123000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-181000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
802000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
886000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
941000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-2974000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
472000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-202000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
864000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-805000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-807000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1144000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
962000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-680000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1169000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
320000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30526000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43505000 usd
gcac Purchases Of Property And Equipment
PurchasesOfPropertyAndEquipment
1292000 usd
gcac Purchases Of Property And Equipment
PurchasesOfPropertyAndEquipment
584000 usd
gcac Purchases Of Shortterm Investments
PurchasesOfShorttermInvestments
37806000 usd
gcac Purchases Of Shortterm Investments
PurchasesOfShorttermInvestments
32368000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8303000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
25200000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
8624000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13898000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16025000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
99884000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
45220000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
76107000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
29031000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
9724000 usd
gcac Proceeds From Issuance Of Common Stock Options Net Of Repurchase
ProceedsFromIssuanceOfCommonStockOptionsNetOfRepurchase
22000 usd
gcac Proceeds From Issuance Of Common Stock Options Net Of Repurchase
ProceedsFromIssuanceOfCommonStockOptionsNetOfRepurchase
707000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
63000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54623000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59207000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-19000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10625000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-342000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34518000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3654000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45143000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3312000 usd
us-gaap Interest Paid Net
InterestPaidNet
63000 usd
us-gaap Interest Paid Net
InterestPaidNet
741000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
12000 usd
gcac Business Combination Transaction Costs Accrued But Not Paid
BusinessCombinationTransactionCostsAccruedButNotPaid
0 usd
gcac Business Combination Transaction Costs Accrued But Not Paid
BusinessCombinationTransactionCostsAccruedButNotPaid
135000 usd
gcac Vesting Of Early Exercises Of Stock Options
VestingOfEarlyExercisesOfStockOptions
0 usd
gcac Vesting Of Early Exercises Of Stock Options
VestingOfEarlyExercisesOfStockOptions
101000 usd
gcac Initial Classification Of Warrant Liability
InitialClassificationOfWarrantLiability
11190000 usd
gcac Initial Classification Of Warrant Liability
InitialClassificationOfWarrantLiability
1827000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43900000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
17300000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-41500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30500000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains a substantial portion of its cash and cash equivalents and short-term investments in money market funds, commercial paper, corporate debt securities, and U.S. government agency securities. Management believes that the financial institutions that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, represent minimal credit risk. Deposits held with banks may exceed the amount of federal insurance limits provided on such deposits.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation and reserves, warranty reserves, valuation allowance for deferred tax assets, valuation of earnout and warrant liabilities, stock-based compensation, useful lives of property and equipment, income tax uncertainties, and other loss contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial condition and results of operations.
gcac Product Warranty Term
ProductWarrantyTerm
P1Y
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Reclassifications</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications.</span></div>
gcac Exchange Ratio
ExchangeRatio
2.449
CY2022Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
595000 shares
gcac Purchase Price Per Share
PurchasePricePerShare
100.00
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
59500000 usd
us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
31700000 usd
us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
2600000 usd
us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
76100000 usd
CY2022Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
40700000 usd
CY2023Q3 us-gaap Revenues
Revenues
3833000 usd
CY2023Q3 gcac Revenue Percent Of Total
RevenuePercentOfTotal
1
CY2022Q3 us-gaap Revenues
Revenues
1804000 usd
CY2022Q3 gcac Revenue Percent Of Total
RevenuePercentOfTotal
1
us-gaap Revenues
Revenues
8105000 usd
gcac Revenue Percent Of Total
RevenuePercentOfTotal
1
us-gaap Revenues
Revenues
5849000 usd
gcac Revenue Percent Of Total
RevenuePercentOfTotal
1
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
600000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
500000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21684000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
17345000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
39029000 usd
CY2023Q3 gcac Warrant Liabilities Fair Value Disclosure
WarrantLiabilitiesFairValueDisclosure
141000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
93000 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
234000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10437000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3703000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
14140000 usd
CY2022Q4 gcac Warrant Liabilities Fair Value Disclosure
WarrantLiabilitiesFairValueDisclosure
440000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
920000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1360000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1862000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1179000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1096000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1141000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
953000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
665000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3911000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2985000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
400000 usd
us-gaap Inventory Write Down
InventoryWriteDown
600000 usd
us-gaap Inventory Write Down
InventoryWriteDown
400000 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
1214000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2533000 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
946000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1376000 usd
CY2023Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
0 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
993000 usd
CY2023Q3 gcac Payroll Taxes Receivable Current
PayrollTaxesReceivableCurrent
0 usd
CY2022Q4 gcac Payroll Taxes Receivable Current
PayrollTaxesReceivableCurrent
865000 usd
CY2023Q3 us-gaap Prepaid Rent
PrepaidRent
151000 usd
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
505000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2311000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6272000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3238000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1851000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1239000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
869000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1999000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
982000 usd
us-gaap Depreciation
Depreciation
400000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
200000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1964000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1300000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
825000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
375000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
572000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
525000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
48000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
65000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3409000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2265000 usd
CY2022Q1 gcac Warrant Liability Issued
WarrantLiabilityIssued
96998 shares
CY2022Q1 gcac Warrant Liabilities Exercise Price
WarrantLiabilitiesExercisePrice
16.89
CY2022Q1 gcac Warrant Liabilities Fair Value Disclosure
WarrantLiabilitiesFairValueDisclosure
1300000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
400000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1800000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1100000 usd
CY2022Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2023Q1 gcac Temporary Equity Incremental Costs
TemporaryEquityIncrementalCosts
1100000 usd
CY2023Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
103000000 usd
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
25.85
CY2022Q4 gcac Temporary Equity Optional Redemption Repurchase Notification Period
TemporaryEquityOptionalRedemptionRepurchaseNotificationPeriod
P30D
CY2022Q4 gcac Preferred Stock Put Right Conversion Percentage
PreferredStockPutRightConversionPercentage
1.10
CY2022Q4 gcac Preferred Stock Fundamental Change Voting Power
PreferredStockFundamentalChangeVotingPower
0.50
CY2022Q4 gcac Preferred Stock Fundamental Change Agreements Exceeding Percent
PreferredStockFundamentalChangeAgreementsExceedingPercent
0.10
CY2023Q3 gcac Common Stock Number Of Votes
CommonStockNumberOfVotes
1 vote
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15846935 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15846935 shares
CY2021Q4 gcac Sale Of Stock Number Of Lowest Closing Common Stock Sales Price
SaleOfStockNumberOfLowestClosingCommonStockSalesPrice
3 salesprice
CY2021Q4 gcac Sale Of Stock Average Sales Price Consecutive Days
SaleOfStockAverageSalesPriceConsecutiveDays
10 salespriceday
CY2022Q3 gcac Business Combination Commitment Fee Obligation Period
BusinessCombinationCommitmentFeeObligationPeriod
P180D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5954000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1426132 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.45
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6486000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.45
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21992 shares
gcac Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceExercisable
1.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
71827 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.86
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1340813 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1028000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1119579 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.88
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1028000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1340813 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
20.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2023Q3 gcac Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Aggregate Instrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAggregateInstrinsicValue
1028000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 usd
gcac Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriodWeightedAverageGrantDateFairValue
25.74
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2335000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2368000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6989000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
202000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
210000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
42000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
42000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
us-gaap Share Based Goods And Nonemployee Services Transaction Modification Of Terms Incremental Compensation Cost
ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost
300000 usd
CY2023Q3 us-gaap Share Price
SharePrice
3.80
CY2022Q4 us-gaap Share Price
SharePrice
12.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.170
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.790
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0532
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0442
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
gcac Earnout Liability Period Of Contingency
EarnoutLiabilityPeriodOfContingency
P3Y
gcac Earnout Liability Period Of Contingency
EarnoutLiabilityPeriodOfContingency
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
100000 usd
gcac Gain Loss On Earnout Liability
GainLossOnEarnoutLiability
800000 usd
CY2022Q3 gcac Gain Loss On Earnout Liability
GainLossOnEarnoutLiability
-1400000 usd
gcac Gain Loss On Earnout Liability
GainLossOnEarnoutLiability
70900000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
gcac Warrants Redemption Notice
WarrantsRedemptionNotice
P30D
gcac Warrants Trading Days Threshold
WarrantsTradingDaysThreshold
20 tradingday
gcac Warrants Consecutive Trading Days Threshold
WarrantsConsecutiveTradingDaysThreshold
30 tradingday
gcac Warrant Non Transferable Or Assignable Period
WarrantNonTransferableOrAssignablePeriod
P30D
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
100000 usd
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
60000 shares
CY2022Q1 gcac Warrant Liability Issued
WarrantLiabilityIssued
96998 shares
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-700000 usd
CY2023Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P1Y
CY2023Q3 us-gaap Lease Cost
LeaseCost
1005000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
598000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
803000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
388000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2271000 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1774000 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1358000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11190000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1827000 usd
CY2023Q3 gcac Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
0 usd
CY2022Q4 gcac Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
121000 usd
CY2023Q3 gcac Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
10457000 usd
CY2022Q4 gcac Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
324000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10457000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
445000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1784000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9217000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
281000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11001000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
492000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M3D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y21D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1448
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1378
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
790000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3250000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3328000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3324000 usd
CY2023Q3 gcac Lessee Operating Lease Liability To Be Paid After Year Three
LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
4215000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14907000 usd
us-gaap Present Value Of Future Insurance Profit Experience Adjustment
PresentValueOfFutureInsuranceProfitExperienceAdjustment
3905000 usd
gcac Net Lease Liabilities
NetLeaseLiabilities
11002000 usd
CY2023Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2100000 usd
CY2022Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
300000 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
4200000 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2100000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15834152 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15568941 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15834152 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
782 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5656287 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1034469 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5834952 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment

Files In Submission

Name View Source Status
gcac-20230930_cal.xml Edgar Link unprocessable
0001498233-23-000087-index-headers.html Edgar Link pending
0001498233-23-000087-index.html Edgar Link pending
0001498233-23-000087.txt Edgar Link pending
0001498233-23-000087-xbrl.zip Edgar Link pending
cptn-20230930xex311junpei.htm Edgar Link pending
cptn-20230930xex312hullxu.htm Edgar Link pending
cptn-20230930xex321junpei.htm Edgar Link pending
cptn-20230930xex322hullxu.htm Edgar Link pending
employmentagreementdatedse.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gcac-20230930.htm Edgar Link pending
gcac-20230930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gcac-20230930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
gcac-20230930_def.xml Edgar Link unprocessable
gcac-20230930_lab.xml Edgar Link unprocessable
gcac-20230930_pre.xml Edgar Link unprocessable
gcac-20230930_htm.xml Edgar Link completed
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending